Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solmaz Sahebjam

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2021
Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
Journal of Neuro-Oncology|July 21, 2025
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024Megan Parker, Kelly Jiang, Anita Kalluri, et al.
Cancer|June 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumorsTimothy A Yap, Olivier Rixe, Capucine Baldini, et al.
Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Journal of Neuro-Oncology|May 4, 2017
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastasesKamran A Ahmed, Sungjune Kim, John Arrington, et al.
NMR in Biomedicine|April 19, 2026
Unique Peritumoral Patterns Unveiled by Quantitative Multiparametric MRI and Their Diagnostic and Prognostic Value in Treated Malignant GliomasKeyi Chai, Puyang Wang, Austin Carmichael, et al.
Current Research in Translational Medicine|April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignanciesCaroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology|September 2, 2016
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trialsBenjamin M Ellingson, Robert J Harris, Davis C Woodworth, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2020
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-Positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2021
Correction: A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor-positive Breast CancerSara M Tolaney, Solmaz Sahebjam, Emilie Le Rhun, et al.
Journal of Neuro-Oncology|July 21, 2025
Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024Megan Parker, Kelly Jiang, Anita Kalluri, et al.
Cancer|June 19, 2025
First-in-human phase 1 study of KHK2455 monotherapy and in combination with mogamulizumab in patients with advanced solid tumorsTimothy A Yap, Olivier Rixe, Capucine Baldini, et al.
Neuro-Oncology|September 1, 2025
Phase IB Study of Avelumab and Whole Brain Radiotherapy (WBRT) in Patients with Leptomeningeal Disease (LMD) from Solid Tumors: Results and Molecular AnalysesYolanda Piña, Vincent Law, Solmaz Sahebjam, et al.
Journal of Neuro-Oncology|May 4, 2017
Outcomes targeting the PD-1/PD-L1 axis in conjunction with stereotactic radiation for patients with non-small cell lung cancer brain metastasesKamran A Ahmed, Sungjune Kim, John Arrington, et al.
NMR in Biomedicine|April 19, 2026
Unique Peritumoral Patterns Unveiled by Quantitative Multiparametric MRI and Their Diagnostic and Prognostic Value in Treated Malignant GliomasKeyi Chai, Puyang Wang, Austin Carmichael, et al.
Current Research in Translational Medicine|April 8, 2018
Celyad's novel CAR T-cell therapy for solid malignanciesCaroline Lonez, Alain Hendlisz, Leila Shaza, et al.
Journal of Neuro-Oncology|August 11, 2019
CDK 4/6 inhibitors and stereotactic radiation in the management of hormone receptor positive breast cancer brain metastasesNicholas B Figura, Thrisha K Potluri, Homan Mohammadi, et al.
Neuro-Oncology|September 2, 2016
Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trialsBenjamin M Ellingson, Robert J Harris, Davis C Woodworth, et al.
Pageof 9